Glide into lipid control. Effective lipid control – plus affordability

Glide into lipid control. Effective lipid control – plus affordability

FENOGLIDE® (fenofibrate) tablets FENOGLIDE® (fenofibrate) tablets

Indication for FENOGLIDE

  • FENOGLIDE is a prescription medication that contains fenofibrate and can help adult patients lower the amount of LDL (bad) cholesterol while also increasing the amount of HDL (good) cholesterol when combined with diet and exercise.
  • FENOGLIDE is also used to treat patients with elevated triglyceride levels when combined with diet and exercise.
  • FENOGLIDE has not been shown to reduce heart disease in patients with type 2 diabetes.

Dosage and Administration

  • FENOGLIDE tablets should be taken once a day with food.
  • FENOGLIDE tablets should be taken 1 hour before or 4 hours after a bile acid resin.

Important Safety Information about FENOGLIDE


  • Talk to your doctor before starting FENOGLIDE if you have a diagnosis of kidney, liver, or gallbladder dysfunction. Your doctor may order additional laboratory tests to monitor your organ function during therapy.
  • You should not take FENOGLIDE if you have severe kidney problems or are receiving dialysis, if you have gallbladder or active liver disease, if you are breastfeeding, or if you are allergic to fenofibrate or any of the other ingredients in FENOGLIDE.
  • Muscle pain and the destruction of muscle tissue have been reported in patients taking fenofibrate. The risk of serious muscle problems is increased when fenofibrate is combined with a statin or colchicine. The risk is even greater in patients of advanced age or patients diagnosed with diabetes, kidney failure, or hypothyroidism.
  • There is a risk of severe bleeding in patients taking fenofibrate while on Coumadin (warfarin sodium) anticoagulation therapy. FENOGLIDE patients taking Coumadin should have their PT/INR values (blood clotting test) closely monitored as their dose of Coumadin may need to be adjusted.


The most common adverse reactions observed with FENOGLIDE therapy are abnormal liver tests, increased liver enzymes, increased creatine phosphokinase (CPK) levels, and nasal congestion.


  • Tell your doctor about all of the medications you take, both prescription and non-prescription drugs, including vitamins and herbal supplements. FENOGLIDE may interact with other medicines you are currently taking. Your doctor may order laboratory testing to monitor these interactions.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

For product information, adverse event reports, and product complaint reports, please contact:

Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183

Please see complete Prescribing Information for FENOGLIDE.pdf

FENOGLIDE is a registered trademark of Santarus, Inc, a wholly owned subsidiary of
Salix Pharmaceuticals, Inc.

The information contained on this page is intended for US residents, healthcare providers, and pharmacists only.


Thank you for signing up. You will receive a confirmation email shortly./p>